Compare SND & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SND | LENZ |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | United States | United States |
| Employees | 318 | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.2M | 198.8M |
| IPO Year | 2016 | 2021 |
| Metric | SND | LENZ |
|---|---|---|
| Price | $4.63 | $5.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 357.6K | ★ 610.6K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.81% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $330,153,000.00 | $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.03 | N/A |
| 52 Week Low | $1.76 | $5.73 |
| 52 Week High | $5.92 | $50.19 |
| Indicator | SND | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 41.89 | 26.32 |
| Support Level | $4.45 | N/A |
| Resistance Level | $5.75 | $10.42 |
| Average True Range (ATR) | 0.35 | 0.43 |
| MACD | -0.07 | -0.05 |
| Stochastic Oscillator | 7.49 | 0.56 |
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics. The company has two reportable segments, Sand and SmartSystems. It derives maximum revenue from Sand segment, which includes both frac sand sales and IPS sales. Geographically, the company derives maximum revenue from United States, followed by Canada.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.